Importantly, these progenitors are likely to also be key cellular targets for recurrent FLT3 driver mutations in patients with acute B‐cell progenitor and ETP leukaemia (Carow et al, 1996; Armstrong et al, 2004; Neumann et al, 2013). This evidence concerns the gene FLT3 and leukemia.